Bupropion found to not improve sexual desire for female cancer survivors
Despite preliminary supporting evidence that the dopaminergic agent bupropion might improve sexual desire for female cancer survivors, the NRG Oncology CC004 clinical trial determined that bupropion did not improve outcomes ...
Dec 10, 2021
0
17